DIGNITANA TO EXHIBIT DIGNICAP® SCALP COOLING SYSTEM AT 2017 SAN ANTONIO BREAST CANCER SYMPOSIUM
Lund, Sweden – December 4, 2017 - Dignitana AB, world leader in medical scalp cooling technology, announced today that The DigniCap® Scalp Cooling System, a patented scalp cooling system that offers cancer patients the ability to keep their hair during chemotherapy, will be exhibited in Booth 532 at the 2017 San Antonio Breast Cancer Symposium (SABCS) December 5 - 9.
One of the world’s most important gatherings of academic and private breast cancer physicians and researchers, SABCS brings together over 7,500 attendees from more than 90 countries to provides state-of-the-art information and updates based on the latest breast cancer medical research and scientific advances.
As the first and only device FDA-cleared for use with solid tumor cancers, medical facilities may use DigniCap® to reduce hair loss in the more than 800,000 women and men in the U.S. treated for solid tumor cancers such as breast, prostate, ovary, uterus, lungs and other tissues.
“We are experiencing an exciting period of growth and are thrilled at the opportunity to again exhibit at SABCS and increase familiarity of scalp cooling among the world’s most respected physicians and researchers,” said William Cronin, CEO of Dignitana, Inc., the U.S. subsidiary of Dignitana AB.
The DigniCap® Scalp Cooling System is available at over 100 cancer clinics in 22 states in the U.S., helping thousands of patients each year minimize chemotherapy-induced hair loss.
Caren Browning Semmy Rülf
King + Company Chairman of the board, Dignitana AB
00 1 212 561-7464 +46 (0)709-312730
About Dignitana AB (publ)
Dignitana is a Swedish public company based in Lund and manufacturer of the medical cooling device DigniCap®. Dignitana AB is listed on Nasdaq First North Stockholm and has appointed Erik Penser Bank as Certified Adviser. Headquartered in Dallas Texas, Dignitana, Inc. is the U.S. subsidiary of Dignitana AB. For more information visit www.dignitana.se and www.dignicap.com
This information is information that Dignitana AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, by the above contact, for publication at 16:45 (CEST), 4 December, 2017.